{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "15",
                "@timestamp": "2022-06-15T14:21:31.000031-04:00",
                "@year": "2022",
                "@month": "06"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "04"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Janssen Biopharma"},
                {"xocs:funding-agency-matched-string": "Janssen Global Services"}
            ],
            "xocs:funding-addon-generated-timestamp": "2022-04-25T22:51:21.135Z",
            "xocs:funding-text": "This study was supported by Janssen Biopharma. Medical writing support was funded by Janssen Global Services, LLC.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "New Zealand",
                            "@afid": "60005686",
                            "@country": "nzl",
                            "city": "Auckland",
                            "organization": [
                                {"$": "New Zealand Liver Transplant Unit"},
                                {"$": "University of Auckland"}
                            ],
                            "affiliation-id": {"@afid": "60005686"},
                            "@affiliation-instance-id": "2017664659-5b25231c37c28d81b27e7ea97115cb5c",
                            "ce:source-text": "New Zealand Liver Transplant Unit, University of Auckland, Auckland, New Zealand"
                        },
                        "author": [{
                            "ce:given-name": "Ed J.",
                            "preferred-name": {
                                "ce:given-name": "Ed J.",
                                "ce:initials": "E.J.",
                                "ce:surname": "Gane",
                                "ce:indexed-name": "Gane E.J."
                            },
                            "@author-instance-id": "2017664659-b55f73746ffec129c1fb82d6529a8c39",
                            "@seq": "1",
                            "ce:initials": "E.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Gane",
                            "@auid": "7003720102",
                            "ce:indexed-name": "Gane E.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "New Zealand",
                            "@afid": "100814963",
                            "@country": "nzl",
                            "city": "Auckland",
                            "organization": {"$": "Auckland Clinical Studies"},
                            "affiliation-id": {"@afid": "100814963"},
                            "@affiliation-instance-id": "2017664659-65d80017f4824d9c4bbe94e86e8303f6",
                            "ce:source-text": "Auckland Clinical Studies, Auckland, New Zealand"
                        },
                        "author": [{
                            "ce:given-name": "Christian",
                            "preferred-name": {
                                "ce:given-name": "Christian",
                                "ce:initials": "C.",
                                "ce:surname": "Schwabe",
                                "ce:indexed-name": "Schwabe C."
                            },
                            "@author-instance-id": "2017664659-415337d756233ba77076b149a8e11067",
                            "@seq": "2",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Schwabe",
                            "@auid": "55711176000",
                            "ce:indexed-name": "Schwabe C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Moldova",
                            "@afid": "100602516",
                            "@country": "mda",
                            "city": "Chisinau",
                            "organization": [
                                {"$": "ARENSIA Exploratory Medicine"},
                                {"$": "Republican Clinical Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "100602516",
                                "@dptid": "114381514"
                            },
                            "@affiliation-instance-id": "2017664659-bae82145d1c818df8ec2c87c3bc111f6",
                            "ce:source-text": "ARENSIA Exploratory Medicine, Republican Clinical Hospital, Chisinau, Moldova",
                            "@dptid": "114381514"
                        },
                        "author": [
                            {
                                "ce:given-name": "Elina",
                                "preferred-name": {
                                    "ce:given-name": "Elina",
                                    "ce:initials": "E.",
                                    "ce:surname": "Berliba",
                                    "ce:indexed-name": "Berliba E."
                                },
                                "@author-instance-id": "2017664659-0edc97c957c6a77daecf85f555dafc72",
                                "@seq": "3",
                                "ce:initials": "E.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Berliba",
                                "@auid": "57204278515",
                                "ce:indexed-name": "Berliba E."
                            },
                            {
                                "ce:given-name": "Alina",
                                "preferred-name": {
                                    "ce:given-name": "Alina",
                                    "ce:initials": "A.",
                                    "ce:surname": "Jucov",
                                    "ce:indexed-name": "Jucov A."
                                },
                                "@author-instance-id": "2017664659-46952bbb80912efe1bbfa645c988d7b6",
                                "@seq": "5",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Jucov",
                                "@auid": "57217017108",
                                "ce:indexed-name": "Jucov A."
                            },
                            {
                                "ce:given-name": "Nelea",
                                "preferred-name": {
                                    "ce:given-name": "Nelea",
                                    "ce:initials": "N.",
                                    "ce:surname": "Ghicavii",
                                    "ce:indexed-name": "Ghicavii N."
                                },
                                "@author-instance-id": "2017664659-a085a59516af658aa2fc2243568d23f2",
                                "@seq": "6",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ghicavii",
                                "@auid": "57201821002",
                                "ce:indexed-name": "Ghicavii N."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Moldova",
                            "@afid": "60071302",
                            "@country": "mda",
                            "city": "Chisinau",
                            "organization": {"$": "State University of Medicine and Pharmacy N. Testemitanu"},
                            "affiliation-id": {"@afid": "60071302"},
                            "@affiliation-instance-id": "2017664659-74400fd37be93493036c74abf81f7dc4",
                            "ce:source-text": "State University of Medicine and Pharmacy N. Testemitanu, Chisinau, Moldova"
                        },
                        "author": [
                            {
                                "ce:given-name": "Elina",
                                "preferred-name": {
                                    "ce:given-name": "Elina",
                                    "ce:initials": "E.",
                                    "ce:surname": "Berliba",
                                    "ce:indexed-name": "Berliba E."
                                },
                                "@author-instance-id": "2017664659-0edc97c957c6a77daecf85f555dafc72",
                                "@seq": "3",
                                "ce:initials": "E.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Berliba",
                                "@auid": "57204278515",
                                "ce:indexed-name": "Berliba E."
                            },
                            {
                                "ce:given-name": "Alina",
                                "preferred-name": {
                                    "ce:given-name": "Alina",
                                    "ce:initials": "A.",
                                    "ce:surname": "Jucov",
                                    "ce:indexed-name": "Jucov A."
                                },
                                "@author-instance-id": "2017664659-46952bbb80912efe1bbfa645c988d7b6",
                                "@seq": "5",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Jucov",
                                "@auid": "57217017108",
                                "ce:indexed-name": "Jucov A."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence in Hepatitis and Liver Cancer"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "127968398"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2017664659-03854f6d812c59296980ae8b2323f338",
                            "ce:source-text": "Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "127968398"
                        },
                        "author": [{
                            "ce:given-name": "Pisit",
                            "preferred-name": {
                                "ce:given-name": "Pisit",
                                "ce:initials": "P.",
                                "ce:surname": "Tangkijvanich",
                                "ce:indexed-name": "Tangkijvanich P."
                            },
                            "@author-instance-id": "2017664659-555cdfd74f572588e871f1542f3bd96e",
                            "@seq": "4",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tangkijvanich",
                            "@auid": "7003646635",
                            "ce:indexed-name": "Tangkijvanich P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Belgium",
                            "@afid": "60068574",
                            "@country": "bel",
                            "city": "Beerse",
                            "organization": [
                                {"$": "Janssen Pharmaceutica"},
                                {"$": "NV"}
                            ],
                            "affiliation-id": {"@afid": "60068574"},
                            "@affiliation-instance-id": "2017664659-931e21a568e5f6f8791ec263155a5322",
                            "ce:source-text": "Janssen Pharmaceutica, NV, Beerse, Belgium"
                        },
                        "author": [
                            {
                                "ce:given-name": "Thierry",
                                "preferred-name": {
                                    "ce:given-name": "Thierry",
                                    "ce:initials": "T.",
                                    "ce:surname": "Verbinnen",
                                    "ce:indexed-name": "Verbinnen T."
                                },
                                "@author-instance-id": "2017664659-c1ba79a27c702aa7057fab2b8fcd9731",
                                "@seq": "7",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Verbinnen",
                                "@auid": "16029873500",
                                "ce:indexed-name": "Verbinnen T."
                            },
                            {
                                "ce:given-name": "Oliver",
                                "preferred-name": {
                                    "ce:given-name": "Oliver",
                                    "ce:initials": "O.",
                                    "ce:surname": "Lenz",
                                    "ce:indexed-name": "Lenz O."
                                },
                                "@author-instance-id": "2017664659-ea69da085fb0efb75f7f5c72a0737b0e",
                                "@seq": "8",
                                "ce:initials": "O.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Lenz",
                                "@auid": "57207906673",
                                "ce:indexed-name": "Lenz O."
                            },
                            {
                                "ce:given-name": "Willem",
                                "preferred-name": {
                                    "ce:given-name": "Willem",
                                    "ce:initials": "W.",
                                    "ce:surname": "Talloen",
                                    "ce:indexed-name": "Talloen W."
                                },
                                "@author-instance-id": "2017664659-aee3c480cf8c60b5404e443158f09472",
                                "@seq": "9",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Talloen",
                                "@auid": "6507412168",
                                "ce:indexed-name": "Talloen W."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "122846115",
                            "@country": "usa",
                            "city": "South San Francisco",
                            "organization": {"$": "Janssen BioPharma Inc."},
                            "affiliation-id": {"@afid": "122846115"},
                            "state": "CA",
                            "@affiliation-instance-id": "2017664659-01f59eb9b96b78dc476041cf37c4ab09",
                            "ce:source-text": "Janssen BioPharma Inc., South San Francisco, CA, USA"
                        },
                        "author": [
                            {
                                "ce:given-name": "Thomas N.",
                                "preferred-name": {
                                    "ce:given-name": "Thomas N.",
                                    "ce:initials": "T.N.",
                                    "ce:surname": "Kakuda",
                                    "ce:indexed-name": "Kakuda T.N."
                                },
                                "@author-instance-id": "2017664659-69c9a3111becc9fa30ff5203dc22df8a",
                                "@seq": "10",
                                "ce:initials": "T.N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kakuda",
                                "@auid": "7006153476",
                                "ce:indexed-name": "Kakuda T.N."
                            },
                            {
                                "ce:given-name": "Chris",
                                "preferred-name": {
                                    "ce:given-name": "Chris",
                                    "ce:initials": "C.",
                                    "ce:surname": "Westland",
                                    "ce:indexed-name": "Westland C."
                                },
                                "@author-instance-id": "2017664659-209f2bf4dfd8fc9f356e6501accf7093",
                                "@seq": "11",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Westland",
                                "@auid": "6602914490",
                                "ce:indexed-name": "Westland C."
                            },
                            {
                                "ce:given-name": "Megha",
                                "preferred-name": {
                                    "ce:given-name": "Megha",
                                    "ce:initials": "M.",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel M."
                                },
                                "@author-instance-id": "2017664659-3da4f6d7a3cfe54aa90da8fd953ad5fe",
                                "@seq": "12",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Patel",
                                "@auid": "57574809900",
                                "ce:indexed-name": "Patel M."
                            },
                            {
                                "ce:given-name": "Jeysen Z.",
                                "preferred-name": {
                                    "ce:given-name": "Jeysen Z.",
                                    "ce:initials": "J.Z.",
                                    "ce:surname": "Yogaratnam",
                                    "ce:indexed-name": "Yogaratnam J.Z."
                                },
                                "@author-instance-id": "2017664659-8efe529fa5e2589cc0e0ae3481a922a0",
                                "@seq": "13",
                                "ce:initials": "J.Z.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Yogaratnam",
                                "@auid": "57205166812",
                                "ce:indexed-name": "Yogaratnam J.Z."
                            },
                            {
                                "ce:given-name": "Leonard",
                                "preferred-name": {
                                    "ce:given-name": "Leonard",
                                    "ce:initials": "L.",
                                    "ce:surname": "Dragone",
                                    "ce:indexed-name": "Dragone L."
                                },
                                "@author-instance-id": "2017664659-d2938ae297a3876ae29fa1b3d8e12628",
                                "@seq": "14",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Dragone",
                                "@auid": "57574889000",
                                "ce:indexed-name": "Dragone L."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60027736",
                            "@country": "usa",
                            "city": "Titusville",
                            "organization": {"$": "Janssen Pharmaceuticals"},
                            "affiliation-id": {"@afid": "60027736"},
                            "state": "NJ",
                            "@affiliation-instance-id": "2017664659-ccfade6db39abd2eee9fccd3728248d0",
                            "ce:source-text": "Janssen Pharmaceuticals, Titusville, NJ, USA"
                        },
                        "author": [{
                            "ce:given-name": "Pieter",
                            "preferred-name": {
                                "ce:given-name": "Pieter",
                                "ce:initials": "P.",
                                "ce:surname": "Van Remoortere",
                                "ce:indexed-name": "Van Remoortere P."
                            },
                            "@author-instance-id": "2017664659-a9b6be4b6f2d0302d8db7f7a93b7c80f",
                            "@seq": "15",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Van Remoortere",
                            "@auid": "23052845600",
                            "ce:indexed-name": "Van Remoortere P."
                        }]
                    }
                ],
                "citation-title": "Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection",
                "abstracts": "Â© 2022 The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.Objectives: We investigated JNJ-64530440 (a hepatitis B virus capsid assembly modulator) safety, antiviral activity and pharmacokinetics in patients with chronic hepatitis B (CHB) (Phase 1b, NCT03439488). Methods: Twenty treatment-naive, HBeAg-positive or -negative CHB patients were randomized 4: 1 to JNJ-64530440 750 mg once or twice daily, or placebo for 28 days. Results: All patients (mean age 43.8 years; 85% male; 70% White; 20% HBeAg positive) completed dosing/28 day follow-up. Mild-to-moderate treatment-emergent adverse events occurred in 3/4 (placebo), 6/8 (once-daily) and 4/8 (twice-daily) patients; mostly fatigue, increased alanine aminotransferase, decreased neutrophil count, and headache. Hepatitis B virus (HBV) DNA was substantially reduced; mean (range) changes from baseline at day 29 were: -3.2 (-2.4 to -3.9) (once-daily) and -3.3 (-2.6 to -4.1) (twice-daily) log10 IU/mL; placebo 0.1 (0.7 to -0.6) log10 IU/mL. HBV DNA levels were below the lower limit of quantification (LLOQ) in 5/8 (once-daily) and 3/8 (twice-daily) patients. For patients with detectable baseline HBV RNA, mean (SE) changes versus baseline in HBV RNA at day 29 were: -2.65 (0.81) (once-daily) and -2.94 (0.33) (twice-daily) log10 copies/mL. HBV RNA levels were 'target not detected' in 4/6 (once-daily) and 3/7 (twice-daily) patients. JNJ-64530440 pharmacokinetics in CHB patients were comparable with those in healthy volunteers. Conclusions: JNJ-64530440 750 mg once-daily or twice-daily for 28 days was well tolerated and achieved potent antiviral activity in CHB patients.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "@country": "usa",
                        "city": "Titusville",
                        "organization": {"$": "Janssen Pharmaceuticals"},
                        "state": "NJ",
                        "ce:source-text": "Janssen Pharmaceuticals, Titusville, NJ, USA"
                    },
                    "person": {
                        "ce:given-name": "Pieter",
                        "ce:initials": "P.",
                        "ce:surname": "Van Remoortere",
                        "ce:indexed-name": "Van Remoortere P."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://jac.oxfordjournals.org/",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Antimicrobial Chemotherapy",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "77",
                            "@issue": "4"
                        },
                        "pagerange": {
                            "@first": "1102",
                            "@last": "1110"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Antimicrobial Chemotherapy",
                    "publicationdate": {
                        "month": "04",
                        "year": "2022",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 April 2022"
                        },
                        "day": "01"
                    },
                    "codencode": "JACHD",
                    "sourcetitle-abbrev": "J. Antimicrob. Chemother.",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "14602091",
                            "@type": "electronic"
                        },
                        {
                            "$": "03057453",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Oxford University Press"},
                    "@srcid": "22418"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "4",
                                    "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "3004"},
                                {"$": "2726"},
                                {"$": "2725"},
                                {"$": "2736"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "PHAR"},
                                {"$": "MEDI"}
                            ]
                        }
                    ]},
                    "tradenamegroup": {"tradenames": [
                        {
                            "trademanuitem": {"tradename": "jnj 64530440"},
                            "@type": "TNM"
                        },
                        {
                            "trademanuitem": [
                                {"tradename": "Abbott Architect"},
                                {"tradename": "COBAS AmpliPrep/COBAS TaqMan HBV Test"},
                                {"tradename": "FibroScan"}
                            ],
                            "@type": "TNV"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "9000-86-6"},
                                        {"$": "9014-30-6"}
                                    ],
                                    "enzyme-commission-number": "EC 2.6.1.2",
                                    "chemical-name": "alanine aminotransferase"
                                },
                                {
                                    "cas-registry-number": "7440-09-7",
                                    "chemical-name": "potassium"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antiviral Agents"},
                                {"chemical-name": "DNA, Viral"},
                                {"chemical-name": "Hepatitis B e Antigens"}
                            ]
                        }
                    ]},
                    "manufacturergroup": {"manufacturers": {
                        "@type": "MNV",
                        "manufacturer": "Hoffmann La Roche"
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was supported by Janssen Biopharma. Medical writing support was funded by Janssen Global Services, LLC.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "14",
                    "@timestamp": "BST 12:57:06",
                    "@year": "2022",
                    "@month": "06"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2017664659",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "637062151",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "939797752",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20220360426",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "35040959",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20221276431",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20221399600",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20229007171277",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85128160115",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85128160115",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "637062151",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76425199",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1093/jac/dkab491"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "24",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Terrault NA, Lok ASF, McMahon BJ et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67: 1560-99.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85044252801",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "1560",
                                    "@last": "1599"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "NA",
                                        "@_fa": "true",
                                        "ce:surname": "Terrault",
                                        "ce:indexed-name": "Terrault NA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "ASF",
                                        "@_fa": "true",
                                        "ce:surname": "Lok",
                                        "ce:indexed-name": "Lok ASF"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BJ",
                                        "@_fa": "true",
                                        "ce:surname": "McMahon",
                                        "ce:indexed-name": "McMahon BJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Terrault NA, Lok ASF, McMahon BJ et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67: 1560-99."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 2017; 67: 370-98.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85017533115",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "370",
                                    "@last": "398"
                                }
                            },
                            "ref-text": "European Association for the Study of the Liver",
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 2017; 67: 370-98."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lok AS, Zoulim F, Dusheiko G et al. Hepatitis B cure: from discovery to regulatory approval. Hepatology 2017; 66: 1296-313.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Hepatitis B cure: from discovery to regulatory approval"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85026547267",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "66"},
                                "pagerange": {
                                    "@first": "1296",
                                    "@last": "1313"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AS",
                                        "@_fa": "true",
                                        "ce:surname": "Lok",
                                        "ce:indexed-name": "Lok AS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Zoulim",
                                        "ce:indexed-name": "Zoulim F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Dusheiko",
                                        "ce:indexed-name": "Dusheiko G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Lok AS, Zoulim F, Dusheiko G et al. Hepatitis B cure: from discovery to regulatory approval. Hepatology 2017; 66: 1296-313."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Berke JM, Dehertogh P, Vergauwen K et al. In vitro antiviral activity and mode of action of JNJ-64530440, a novel potent hepatitis B virus capsid assembly modulator in clinical development. Hepatology 2018; 68 Suppl: 239A.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "In vitro antiviral activity and mode of action of JNJ-64530440, a novel potent hepatitis B virus capsid assembly modulator in clinical development"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85085532437",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {"@first": "239A"}
                            },
                            "ref-text": "Suppl",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Berke",
                                        "ce:indexed-name": "Berke JM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Dehertogh",
                                        "ce:indexed-name": "Dehertogh P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Vergauwen",
                                        "ce:indexed-name": "Vergauwen K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Berke JM, Dehertogh P, Vergauwen K et al. In vitro antiviral activity and mode of action of JNJ-64530440, a novel potent hepatitis B virus capsid assembly modulator in clinical development. Hepatology 2018; 68 Suppl: 239A."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Zhao N, Jia B, Zhao H et al. A first-in-human trial of GLS4, a novel inhibitor of hepatitis B virus capsid assembly, following single-and multiple-ascending-oral-dose studies with or without ritonavir in healthy adult volunteers. Antimicrob Agents Chemother 2019; 64: e01686-19.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "A first-in-human trial of GLS4, a novel inhibitor of hepatitis B virus capsid assembly, following single-and multiple-ascending-oral-dose studies with or without ritonavir in healthy adult volunteers"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85077016675",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "e01686",
                                    "@last": "19"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Zhao",
                                        "ce:indexed-name": "Zhao N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Jia",
                                        "ce:indexed-name": "Jia B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Zhao",
                                        "ce:indexed-name": "Zhao H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Zhao N, Jia B, Zhao H et al. A first-in-human trial of GLS4, a novel inhibitor of hepatitis B virus capsid assembly, following single-and multiple-ascending-oral-dose studies with or without ritonavir in healthy adult volunteers. Antimicrob Agents Chemother 2019; 64: e01686-19."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Zhang H, Wang F, Zhu X, et al. Antiviral activity and pharmacokinetics of the HBV capsid assembly modulator GLS4 in patients with chronic HBV infection. Clin Infect Dis 2020; 73:175-82.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Antiviral activity and pharmacokinetics of the HBV capsid assembly modulator GLS4 in patients with chronic HBV infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85112125045",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "175",
                                    "@last": "182"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X",
                                        "@_fa": "true",
                                        "ce:surname": "Zhu",
                                        "ce:indexed-name": "Zhu X"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Zhang H, Wang F, Zhu X, et al. Antiviral activity and pharmacokinetics of the HBV capsid assembly modulator GLS4 in patients with chronic HBV infection. Clin Infect Dis 2020; 73:175-82."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Feng S, Gane E, Schwabe C et al. A five-in-one first-in-human study to assess safety, tolerability, and pharmacokinetics of RO7049389, an inhibitor of hepatitis B virus capsid assembly, after single and multiple ascending doses in healthy participants. Antimicrob Agents Chemother 2020; 64: e01323-20.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A five-in-one first-in-human study to assess safety, tolerability, and pharmacokinetics of RO7049389, an inhibitor of hepatitis B virus capsid assembly, after single and multiple ascending doses in healthy participants"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85094221976",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "e01323",
                                    "@last": "20"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Feng",
                                        "ce:indexed-name": "Feng S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Gane",
                                        "ce:indexed-name": "Gane E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Schwabe",
                                        "ce:indexed-name": "Schwabe C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Feng S, Gane E, Schwabe C et al. A five-in-one first-in-human study to assess safety, tolerability, and pharmacokinetics of RO7049389, an inhibitor of hepatitis B virus capsid assembly, after single and multiple ascending doses in healthy participants. Antimicrob Agents Chemother 2020; 64: e01323-20."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Gane E, Liu A, Yuen M-F et al. RO7049389, a core protein allosteric modulator, demonstrates robust anti-HBV activity in chronic hepatitis B patients and is safe and well tolerated. J Hepatol 2018; 68 Suppl 1: S101.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "RO7049389, a core protein allosteric modulator, demonstrates robust anti-HBV activity in chronic hepatitis B patients and is safe and well tolerated"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85060099650",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {"@first": "S101"}
                            },
                            "ref-text": "Suppl 1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Gane",
                                        "ce:indexed-name": "Gane E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M-F",
                                        "@_fa": "true",
                                        "ce:surname": "Yuen",
                                        "ce:indexed-name": "Yuen M-F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Gane E, Liu A, Yuen M-F et al. RO7049389, a core protein allosteric modulator, demonstrates robust anti-HBV activity in chronic hepatitis B patients and is safe and well tolerated. J Hepatol 2018; 68 Suppl 1: S101."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Berke JM, Dehertogh P, Vergauwen K et al. Antiviral properties and mechanism of action studies of the hepatitis B virus capsid assembly modulator JNJ-56136379. Antimicrob Agents Chemother 2020; 64: e02439-19.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Antiviral properties and mechanism of action studies of the hepatitis B virus capsid assembly modulator JNJ-56136379"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85083655944",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "e02439",
                                    "@last": "19"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Berke",
                                        "ce:indexed-name": "Berke JM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Dehertogh",
                                        "ce:indexed-name": "Dehertogh P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Vergauwen",
                                        "ce:indexed-name": "Vergauwen K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Berke JM, Dehertogh P, Vergauwen K et al. Antiviral properties and mechanism of action studies of the hepatitis B virus capsid assembly modulator JNJ-56136379. Antimicrob Agents Chemother 2020; 64: e02439-19."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kakuda TN, Yogaratnam JZ, Westland CW et al. JNJ-64530440, a novel capsid assembly modulator: single-and multiple-ascending dose safety, tolerability and pharmacokinetics in healthy volunteers. J Hepatol 2019; 70 Suppl 1: e469.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "JNJ-64530440, a novel capsid assembly modulator: single-and multiple-ascending dose safety, tolerability and pharmacokinetics in healthy volunteers"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85071615370",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "70"},
                                "pagerange": {"@first": "e469"}
                            },
                            "ref-text": "Suppl 1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "TN",
                                        "@_fa": "true",
                                        "ce:surname": "Kakuda",
                                        "ce:indexed-name": "Kakuda TN"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JZ",
                                        "@_fa": "true",
                                        "ce:surname": "Yogaratnam",
                                        "ce:indexed-name": "Yogaratnam JZ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CW",
                                        "@_fa": "true",
                                        "ce:surname": "Westland",
                                        "ce:indexed-name": "Westland CW"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Kakuda TN, Yogaratnam JZ, Westland CW et al. JNJ-64530440, a novel capsid assembly modulator: single-and multiple-ascending dose safety, tolerability and pharmacokinetics in healthy volunteers. J Hepatol 2019; 70 Suppl 1: e469."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Poynard T, Vergniol J, Ngo Y et al. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTestÂ® ) and elastography (FibroScanÂ® ). J Hepatol 2014; 61: 994-1003.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTestÂ® ) and elastography (FibroScanÂ® )"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84932111887",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "994",
                                    "@last": "1003"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Poynard",
                                        "ce:indexed-name": "Poynard T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Vergniol",
                                        "ce:indexed-name": "Vergniol J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Ngo",
                                        "ce:indexed-name": "Ngo Y"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Poynard T, Vergniol J, Ngo Y et al. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTestÂ® ) and elastography (FibroScanÂ® ). J Hepatol 2014; 61: 994-1003."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Marcellin P, Ziol M, Bedossa P et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-7.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B"},
                            "refd-itemidlist": {"itemid": {
                                "$": "58149510576",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "242",
                                    "@last": "247"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Marcellin",
                                        "ce:indexed-name": "Marcellin P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Ziol",
                                        "ce:indexed-name": "Ziol M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Bedossa",
                                        "ce:indexed-name": "Bedossa P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Liver Int"
                        },
                        "ce:source-text": "Marcellin P, Ziol M, Bedossa P et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-7."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "NIAID Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events. Corrected version 2.1. 2017. https://rsc. niaid.nih.gov/sites/default/files/daidsgradingcorrectedv21.pdf.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://rsc.niaid.nih.gov/sites/default/files/daidsgradingcorrectedv21.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85056707406",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "NIAID Division of AIDS (DAIDS) Corrected version 2.1",
                            "ref-sourcetitle": "Table for Grading the Severity of Adult and Pediatric Adverse Events"
                        },
                        "ce:source-text": "NIAID Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events. Corrected version 2.1. 2017. https://rsc. niaid.nih.gov/sites/default/files/daidsgradingcorrectedv21.pdf."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "ZoulimF, Lenz O, Vandenbossche JJ et al. JNJ-56136379, an HBVcapsid assembly modulator, is well-tolerated and has antiviral activity in a phase 1 study of patients with chronic infection. Gastroenterology 2020; 159: 521-33.e9.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "JNJ-56136379, an HBVcapsid assembly modulator, is well-tolerated and has antiviral activity in a phase 1 study of patients with chronic infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85089515679",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "159"},
                                "pagerange": {
                                    "@first": "521",
                                    "@last": "533"
                                }
                            },
                            "ref-text": "e9",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Zoulim",
                                        "ce:indexed-name": "Zoulim F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O",
                                        "@_fa": "true",
                                        "ce:surname": "Lenz",
                                        "ce:indexed-name": "Lenz O"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JJ",
                                        "@_fa": "true",
                                        "ce:surname": "Vandenbossche",
                                        "ce:indexed-name": "Vandenbossche JJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "ZoulimF, Lenz O, Vandenbossche JJ et al. JNJ-56136379, an HBVcapsid assembly modulator, is well-tolerated and has antiviral activity in a phase 1 study of patients with chronic infection. Gastroenterology 2020; 159: 521-33.e9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Verbinnen T, Tan Y, Wang G et al. Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136397 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro. J Antimicrob Chemother 2020; 75: 2526-34.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136397 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85089541785",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "75"},
                                "pagerange": {
                                    "@first": "2526",
                                    "@last": "2534"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Verbinnen",
                                        "ce:indexed-name": "Verbinnen T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan Y"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Verbinnen T, Tan Y, Wang G et al. Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136397 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro. J Antimicrob Chemother 2020; 75: 2526-34."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Yuen M-F, Agarwal K, Gane EJ et al. Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial. Lancet Gastroenterol Hepatol 2020; 5: 152-66.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85077384142",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "152",
                                    "@last": "166"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M-F",
                                        "@_fa": "true",
                                        "ce:surname": "Yuen",
                                        "ce:indexed-name": "Yuen M-F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Agarwal",
                                        "ce:indexed-name": "Agarwal K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "EJ",
                                        "@_fa": "true",
                                        "ce:surname": "Gane",
                                        "ce:indexed-name": "Gane EJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Yuen M-F, Agarwal K, Gane EJ et al. Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial. Lancet Gastroenterol Hepatol 2020; 5: 152-66."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Yuen MF, Gane EJ, Kim DJ et al. Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection. Gastroenterology 2019; 156: 1392-403.e7.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85063411210",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "156"},
                                "pagerange": {
                                    "@first": "1392",
                                    "@last": "1403"
                                }
                            },
                            "ref-text": "e7",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Yuen",
                                        "ce:indexed-name": "Yuen MF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "EJ",
                                        "@_fa": "true",
                                        "ce:surname": "Gane",
                                        "ce:indexed-name": "Gane EJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DJ",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim DJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Yuen MF, Gane EJ, Kim DJ et al. Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection. Gastroenterology 2019; 156: 1392-403.e7."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lam AM, Ren S, Espiritu C et al. Hepatitis B virus capsid assembly modulators, but not nucleoside analogs, inhibit the production of extracellular pregenomic RNA and spliced RNA variants. Antimicrob Agents Chemother 2017; 61: e00680-17.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Hepatitis B virus capsid assembly modulators, but not nucleoside analogs, inhibit the production of extracellular pregenomic RNA and spliced RNA variants"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85026386600",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "e00680",
                                    "@last": "17"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AM",
                                        "@_fa": "true",
                                        "ce:surname": "Lam",
                                        "ce:indexed-name": "Lam AM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Ren",
                                        "ce:indexed-name": "Ren S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Espiritu",
                                        "ce:indexed-name": "Espiritu C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Lam AM, Ren S, Espiritu C et al. Hepatitis B virus capsid assembly modulators, but not nucleoside analogs, inhibit the production of extracellular pregenomic RNA and spliced RNA variants. Antimicrob Agents Chemother 2017; 61: e00680-17."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Berke JM, Dehertogh P, Vergauwen K et al. Capsid assembly modulators have a dual mechanism of action in primary human hepatocytes infected with hepatitis B virus. Antimicrob Agents Chemother 2017; 61: e00560-17.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Capsid assembly modulators have a dual mechanism of action in primary human hepatocytes infected with hepatitis B virus"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85026348390",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "e00560",
                                    "@last": "17"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Berke",
                                        "ce:indexed-name": "Berke JM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Dehertogh",
                                        "ce:indexed-name": "Dehertogh P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Vergauwen",
                                        "ce:indexed-name": "Vergauwen K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Berke JM, Dehertogh P, Vergauwen K et al. Capsid assembly modulators have a dual mechanism of action in primary human hepatocytes infected with hepatitis B virus. Antimicrob Agents Chemother 2017; 61: e00560-17."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Wong DK-H, Seto W-K, Fung J et al. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency. Clin Gastroenterol Hepatol 2013; 11: 1004-10.e1",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84880608443",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "1004",
                                    "@last": "1010"
                                }
                            },
                            "ref-text": "e1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DK-H",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong DK-H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W-K",
                                        "@_fa": "true",
                                        "ce:surname": "Seto",
                                        "ce:indexed-name": "Seto W-K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Fung",
                                        "ce:indexed-name": "Fung J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Wong DK-H, Seto W-K, Fung J et al. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency. Clin Gastroenterol Hepatol 2013; 11: 1004-10.e1"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Anikhindi SA, Kumar A, Sharma P et al. Ideal cure for hepatitis infection: the target is in sight. J Clin Exp Hepatol 2018; 8: 188-94.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Ideal cure for hepatitis infection: the target is in sight"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85034446112",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "188",
                                    "@last": "194"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Anikhindi",
                                        "ce:indexed-name": "Anikhindi SA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Kumar",
                                        "ce:indexed-name": "Kumar A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Sharma",
                                        "ce:indexed-name": "Sharma P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Exp Hepatol"
                        },
                        "ce:source-text": "Anikhindi SA, Kumar A, Sharma P et al. Ideal cure for hepatitis infection: the target is in sight. J Clin Exp Hepatol 2018; 8: 188-94."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Wang M-L, Liao J, Wei B et al. Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy. Infect Dis (Lond) 2018; 50: 522-30.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85042230290",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "50"},
                                "pagerange": {
                                    "@first": "522",
                                    "@last": "530"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M-L",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang M-L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Liao",
                                        "ce:indexed-name": "Liao J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Wei",
                                        "ce:indexed-name": "Wei B"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Infect Dis (Lond)"
                        },
                        "ce:source-text": "Wang M-L, Liao J, Wei B et al. Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy. Infect Dis (Lond) 2018; 50: 522-30."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Testoni B, LebossÃ© F, Scholtes C et al. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients. J Hepatol 2019; 70: 615-25.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85059699081",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "70"},
                                "pagerange": {
                                    "@first": "615",
                                    "@last": "625"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Testoni",
                                        "ce:indexed-name": "Testoni B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "LebossÃ©",
                                        "ce:indexed-name": "Lebosse F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Scholtes",
                                        "ce:indexed-name": "Scholtes C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Testoni B, LebossÃ© F, Scholtes C et al. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients. J Hepatol 2019; 70: 615-25."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Yuen MF, Berliba E, Sukeepaisarnjaroen W et al. Pharmacokinetics and antiviral activity of the capsid inhibitor AB-506 in healthy subjects and chronic hepatitis B subjects. American Association for the Study of Liver Diseases (AASLD) The Liver Meeting, Boston, MA, 2019. Abstract LP7.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Pharmacokinetics and antiviral activity of the capsid inhibitor AB-506 in healthy subjects and chronic hepatitis B subjects"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85128505179",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Boston, MA, Abstract LP7",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Yuen",
                                        "ce:indexed-name": "Yuen MF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Berliba",
                                        "ce:indexed-name": "Berliba E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Sukeepaisarnjaroen",
                                        "ce:indexed-name": "Sukeepaisarnjaroen W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "American Association for the Study of Liver Diseases (AASLD) The Liver Meeting"
                        },
                        "ce:source-text": "Yuen MF, Berliba E, Sukeepaisarnjaroen W et al. Pharmacokinetics and antiviral activity of the capsid inhibitor AB-506 in healthy subjects and chronic hepatitis B subjects. American Association for the Study of Liver Diseases (AASLD) The Liver Meeting, Boston, MA, 2019. Abstract LP7."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Chisinau",
            "@id": "60071302",
            "affilname": "Nicolae Testemitanu State University of Medicine and Pharmacy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071302",
            "affiliation-country": "Moldova"
        },
        {
            "affiliation-city": "Beerse",
            "@id": "60068574",
            "affilname": "Janssen Pharmaceutica, Headquarters",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068574",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Titusville",
            "@id": "60027736",
            "affilname": "Janssen Pharmaceuticals, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027736",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Auckland",
            "@id": "60005686",
            "affilname": "The University of Auckland",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005686",
            "affiliation-country": "New Zealand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "122846115",
            "affilname": "Janssen Biopharma",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122846115",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Auckland",
            "@id": "100814963",
            "affilname": "Auckland Clinical Studies",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100814963",
            "affiliation-country": "New Zealand"
        },
        {
            "affiliation-city": "Chisinau",
            "@id": "100602516",
            "affilname": "Republican Clinical Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100602516",
            "affiliation-country": "Moldova"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85128160115",
        "dc:description": "Objectives: We investigated JNJ-64530440 (a hepatitis B virus capsid assembly modulator) safety, antiviral activity and pharmacokinetics in patients with chronic hepatitis B (CHB) (Phase 1b, NCT03439488). Methods: Twenty treatment-naive, HBeAg-positive or -negative CHB patients were randomized 4: 1 to JNJ-64530440 750 mg once or twice daily, or placebo for 28 days. Results: All patients (mean age 43.8 years; 85% male; 70% White; 20% HBeAg positive) completed dosing/28 day follow-up. Mild-to-moderate treatment-emergent adverse events occurred in 3/4 (placebo), 6/8 (once-daily) and 4/8 (twice-daily) patients; mostly fatigue, increased alanine aminotransferase, decreased neutrophil count, and headache. Hepatitis B virus (HBV) DNA was substantially reduced; mean (range) changes from baseline at day 29 were: -3.2 (-2.4 to -3.9) (once-daily) and -3.3 (-2.6 to -4.1) (twice-daily) log10 IU/mL; placebo 0.1 (0.7 to -0.6) log10 IU/mL. HBV DNA levels were below the lower limit of quantification (LLOQ) in 5/8 (once-daily) and 3/8 (twice-daily) patients. For patients with detectable baseline HBV RNA, mean (SE) changes versus baseline in HBV RNA at day 29 were: -2.65 (0.81) (once-daily) and -2.94 (0.33) (twice-daily) log10 copies/mL. HBV RNA levels were 'target not detected' in 4/6 (once-daily) and 3/7 (twice-daily) patients. JNJ-64530440 pharmacokinetics in CHB patients were comparable with those in healthy volunteers. Conclusions: JNJ-64530440 750 mg once-daily or twice-daily for 28 days was well tolerated and achieved potent antiviral activity in CHB patients.",
        "pubmed-id": "35040959",
        "prism:coverDate": "2022-04-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85128160115",
        "dc:creator": {"author": [{
            "ce:given-name": "Ed J.",
            "preferred-name": {
                "ce:given-name": "Ed J.",
                "ce:initials": "E.J.",
                "ce:surname": "Gane",
                "ce:indexed-name": "Gane E.J."
            },
            "@seq": "1",
            "ce:initials": "E.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005686",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005686"
            },
            "ce:surname": "Gane",
            "@auid": "7003720102",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003720102",
            "ce:indexed-name": "Gane E.J."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85128160115"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85128160115&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85128160115&origin=inward"
            }
        ],
        "source-id": "22418",
        "citedby-count": "3",
        "prism:volume": "77",
        "subtype": "ar",
        "dc:title": "Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection",
        "openaccess": "1",
        "prism:issn": "14602091 03057453",
        "publishercopyright": "Â© 2022 The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.",
        "prism:issueIdentifier": "4",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Antimicrobial Chemotherapy",
        "prism:pageRange": "1102-1110",
        "prism:endingPage": "1110",
        "openaccessFlag": "true",
        "prism:doi": "10.1093/jac/dkab491",
        "prism:startingPage": "1102",
        "dc:identifier": "SCOPUS_ID:85128160115",
        "dc:publisher": "Oxford University Press"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antiviral Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Capsid",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "DNA, Viral",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hepatitis B e Antigens",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hepatitis B virus",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hepatitis B, Chronic",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Ed J.",
            "preferred-name": {
                "ce:given-name": "Ed J.",
                "ce:initials": "E.J.",
                "ce:surname": "Gane",
                "ce:indexed-name": "Gane E.J."
            },
            "@seq": "1",
            "ce:initials": "E.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005686",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005686"
            },
            "ce:surname": "Gane",
            "@auid": "7003720102",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003720102",
            "ce:indexed-name": "Gane E.J."
        },
        {
            "ce:given-name": "Christian",
            "preferred-name": {
                "ce:given-name": "Christian",
                "ce:initials": "C.",
                "ce:surname": "Schwabe",
                "ce:indexed-name": "Schwabe C."
            },
            "@seq": "2",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "100814963",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100814963"
            },
            "ce:surname": "Schwabe",
            "@auid": "55711176000",
            "author-url": "https://api.elsevier.com/content/author/author_id/55711176000",
            "ce:indexed-name": "Schwabe C."
        },
        {
            "ce:given-name": "Elina",
            "preferred-name": {
                "ce:given-name": "Elina",
                "ce:initials": "E.",
                "ce:surname": "Berliba",
                "ce:indexed-name": "Berliba E."
            },
            "@seq": "3",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "100602516",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100602516"
                },
                {
                    "@id": "60071302",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071302"
                }
            ],
            "ce:surname": "Berliba",
            "@auid": "57204278515",
            "author-url": "https://api.elsevier.com/content/author/author_id/57204278515",
            "ce:indexed-name": "Berliba E."
        },
        {
            "ce:given-name": "Pisit",
            "preferred-name": {
                "ce:given-name": "Pisit",
                "ce:initials": "P.",
                "ce:surname": "Tangkijvanich",
                "ce:indexed-name": "Tangkijvanich P."
            },
            "@seq": "4",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Tangkijvanich",
            "@auid": "7003646635",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003646635",
            "ce:indexed-name": "Tangkijvanich P."
        },
        {
            "ce:given-name": "Alina",
            "preferred-name": {
                "ce:given-name": "Alina",
                "ce:initials": "A.",
                "ce:surname": "Jucov",
                "ce:indexed-name": "Jucov A."
            },
            "@seq": "5",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "100602516",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100602516"
                },
                {
                    "@id": "60071302",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071302"
                }
            ],
            "ce:surname": "Jucov",
            "@auid": "57217017108",
            "author-url": "https://api.elsevier.com/content/author/author_id/57217017108",
            "ce:indexed-name": "Jucov A."
        },
        {
            "ce:given-name": "Nelea",
            "preferred-name": {
                "ce:given-name": "Nelea",
                "ce:initials": "N.",
                "ce:surname": "Ghicavii",
                "ce:indexed-name": "Ghicavii N."
            },
            "@seq": "6",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "100602516",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100602516"
            },
            "ce:surname": "Ghicavii",
            "@auid": "57201821002",
            "author-url": "https://api.elsevier.com/content/author/author_id/57201821002",
            "ce:indexed-name": "Ghicavii N."
        },
        {
            "ce:given-name": "Thierry",
            "preferred-name": {
                "ce:given-name": "Thierry",
                "ce:initials": "T.",
                "ce:surname": "Verbinnen",
                "ce:indexed-name": "Verbinnen T."
            },
            "@seq": "7",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60068574",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068574"
            },
            "ce:surname": "Verbinnen",
            "@auid": "16029873500",
            "author-url": "https://api.elsevier.com/content/author/author_id/16029873500",
            "ce:indexed-name": "Verbinnen T."
        },
        {
            "ce:given-name": "Oliver",
            "preferred-name": {
                "ce:given-name": "Oliver",
                "ce:initials": "O.",
                "ce:surname": "Lenz",
                "ce:indexed-name": "Lenz O."
            },
            "@seq": "8",
            "ce:initials": "O.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60068574",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068574"
            },
            "ce:surname": "Lenz",
            "@auid": "57207906673",
            "author-url": "https://api.elsevier.com/content/author/author_id/57207906673",
            "ce:indexed-name": "Lenz O."
        },
        {
            "ce:given-name": "Willem",
            "preferred-name": {
                "ce:given-name": "Willem",
                "ce:initials": "W.",
                "ce:surname": "Talloen",
                "ce:indexed-name": "Talloen W."
            },
            "@seq": "9",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60068574",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068574"
            },
            "ce:surname": "Talloen",
            "@auid": "6507412168",
            "author-url": "https://api.elsevier.com/content/author/author_id/6507412168",
            "ce:indexed-name": "Talloen W."
        },
        {
            "ce:given-name": "Thomas N.",
            "preferred-name": {
                "ce:given-name": "Thomas N.",
                "ce:initials": "T.N.",
                "ce:surname": "Kakuda",
                "ce:indexed-name": "Kakuda T.N."
            },
            "@seq": "10",
            "ce:initials": "T.N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "122846115",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122846115"
            },
            "ce:surname": "Kakuda",
            "@auid": "7006153476",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006153476",
            "ce:indexed-name": "Kakuda T.N."
        },
        {
            "ce:given-name": "Chris",
            "preferred-name": {
                "ce:given-name": "Chris",
                "ce:initials": "C.",
                "ce:surname": "Westland",
                "ce:indexed-name": "Westland C."
            },
            "@seq": "11",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "122846115",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122846115"
            },
            "ce:surname": "Westland",
            "@auid": "6602914490",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602914490",
            "ce:indexed-name": "Westland C."
        },
        {
            "ce:given-name": "Megha",
            "preferred-name": {
                "ce:given-name": "Megha",
                "ce:initials": "M.",
                "ce:surname": "Patel",
                "ce:indexed-name": "Patel M."
            },
            "@seq": "12",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "122846115",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122846115"
            },
            "ce:surname": "Patel",
            "@auid": "57574809900",
            "author-url": "https://api.elsevier.com/content/author/author_id/57574809900",
            "ce:indexed-name": "Patel M."
        },
        {
            "ce:given-name": "Jeysen Z.",
            "preferred-name": {
                "ce:given-name": "Jeysen Z.",
                "ce:initials": "J.Z.",
                "ce:surname": "Yogaratnam",
                "ce:indexed-name": "Yogaratnam J.Z."
            },
            "@seq": "13",
            "ce:initials": "J.Z.",
            "@_fa": "true",
            "affiliation": {
                "@id": "122846115",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122846115"
            },
            "ce:surname": "Yogaratnam",
            "@auid": "57205166812",
            "author-url": "https://api.elsevier.com/content/author/author_id/57205166812",
            "ce:indexed-name": "Yogaratnam J.Z."
        },
        {
            "ce:given-name": "Leonard",
            "preferred-name": {
                "ce:given-name": "Leonard",
                "ce:initials": "L.",
                "ce:surname": "Dragone",
                "ce:indexed-name": "Dragone L."
            },
            "@seq": "14",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "122846115",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122846115"
            },
            "ce:surname": "Dragone",
            "@auid": "57574889000",
            "author-url": "https://api.elsevier.com/content/author/author_id/57574889000",
            "ce:indexed-name": "Dragone L."
        },
        {
            "ce:given-name": "Pieter",
            "preferred-name": {
                "ce:given-name": "Pieter",
                "ce:initials": "P.",
                "ce:surname": "Van Remoortere",
                "ce:indexed-name": "Van Remoortere P."
            },
            "@seq": "15",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60027736",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027736"
            },
            "ce:surname": "Van Remoortere",
            "@auid": "23052845600",
            "author-url": "https://api.elsevier.com/content/author/author_id/23052845600",
            "ce:indexed-name": "Van Remoortere P."
        }
    ]}
}}